Market Overview

Morning Market Movers

Related NVGN
12 Biggest Mid-Day Losers For Thursday
Novogen Receives $4.4M R&D Tax Rebate
Related FURX
Benzinga's M&A Chatter for Monday April 28, 2014
Forest Labs To Acquire Furiex Pharma A Deal Potentially Worth $1.46 Billion

Novogen (NASDAQ: NVGN) surged 48.66% to $2.9840 at 9:45 am. Novogen shares have jumped 136.43% over the past 52 weeks, while the S&P 500 index has gained 14.47% in the same period.

Furiex Pharmaceuticals (NASDAQ: FURX) shares advanced 47.13% to $31.25. Analysts at Canaccord initiated coverage on shares of Furiex with a “buy” rating..

Keryx Biopharmaceuticals (NASDAQ: KERX) surged 43.76% to $4.93. Keryx Biopharmaceuticals announced successful top-line results from the long-term Phase 3 study of Zerenex™ for the treatment of hyperphosphatemia in patients with end-stage renal disease on dialysis.

Idenix Pharmaceuticals (NASDAQ: IDIX) climbed 13.09% to $5.35. Idenix Pharmaceuticals announced a non-exclusive collaboration with Janssen Pharmaceuticals to initiate Phase II All-oral combination studies.

Posted-In: market moversNews Intraday Update Markets Movers


Related Articles (IDIX + FURX)

View Comments and Join the Discussion!

Partner Center